GlassScriptPhysician profile
Jacob G Unger
NPI 1023245602
$153,360.47
in general payments reported to CMS, 2019-2025
22 companies · $7,293 in 2025
The $7,293 reported for 2025 was more than what 94% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $3,965 · 2021: $2,934 · 2022: $107K · 2023: $1,111 · 2024: $1,738 · 2025: $7,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,750 · Food and Beverage: $3,768 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $513 · Gift: $87.00 · Travel and Lodging: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,750.00 |
| Food and Beverage | $3,767.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $512.50 |
| Gift | $87.00 |
| Travel and Lodging | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Innovation Associates, INC. | $105,655.81 | 2022 | |
| Allergan, INC. | $32,196.00 | 2019-2022 | |
| Motiva USA, LLC | $6,999.71 | 2024-2025 | |
| Elutia, INC. | $3,690.12 | 2020-2021 | |
| Abbvie INC. | $1,883.14 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Davol INC. | $580.29 | 2022-2024 | Phasix Mesh |
| Tela Bio, INC. | $566.24 | 2022-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bard Peripheral Vascular, INC. | $501.47 | 2021 | |
| Integra Lifesciences Corporation | $226.42 | 2019-2024 | Integra, Omnigraft, Surgimend |
| Sientra, INC. | $174.76 | 2019-2022 | |
| Tepha INC | $168.44 | 2019 | |
| Endo Pharmaceuticals INC. | $147.46 | 2019 | |
| Kerecis Limited | $127.49 | 2021 | |
| Acell, INC. | $118.54 | 2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $82.48 | 2022-2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $82.20 | 2024 | Daxxify |
| Mentor Worldwide LLC | $40.48 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Baxter Healthcare | $34.14 | 2025 | |
| Galderma Laboratories, L.P. | $27.93 | 2020-2023 | |
| Musculoskeletal Transplant Foundation INC. | $26.41 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $16.64 | 2022 | |
| Melinta Therapeutics, LLC | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Unger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.